Patent 10526307 was granted and assigned to ADT Pharmaceuticals, LLC on January, 2020 by the United States Patent and Trademark Office.
Disclosed are compounds, for example, compounds of formula (I), (Formula (I) wherein R, R0, R1-R8, n, X, Y, Y′, and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition, for example, cancer.